Halozyme Therapeutics (HALO) Consolidated Net Income (2010 - 2026)
Halozyme Therapeutics (HALO) recorded Consolidated Net Income of $229.9 million in Q2 2026, up 39.2% from $165.16 million a year earlier and up 53.2% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Consolidated Net Income (2010 - 2026) Analysis & Trends
On a TTM basis, Halozyme Therapeutics' Consolidated Net Income came in at $413.56 million as of Jun 30, 2026, down 25.8% year-over-year; for FY2025, it came in at $316.89 million, down 28.6% from FY2024.
- Annual Consolidated Net Income has a five-year compound annual growth rate of 19.7% (FY2020 to FY2025).
- Across earlier years, Consolidated Net Income came in at $444.09 million in FY2024 (+57.7%), $281.59 million in FY2023 (+39.3%), $202.13 million in FY2022 (-49.8%) and $402.71 million in FY2021 (+212.0%).
- The Q2 2026 figure is the highest quarterly Consolidated Net Income in data going back to Q2 2010.
- Peak year-over-year performance for Consolidated Net Income in the last five years was growth of 498.2% in Q3 2021, against a decline of 75.2% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $150.03 million (Q1 2026), -$141.59 million (Q4 2025) and $175.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Halozyme Therapeutics | 12.53 Bn | 11.13 Bn | 401.83 Mn | 229.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 229.90 Mn |
| Mar 31, 2026 | 150.03 Mn |
| Dec 31, 2025 | -141.59 Mn |
| Sep 30, 2025 | 175.23 Mn |
| Jun 30, 2025 | 165.16 Mn |
| Mar 31, 2025 | 118.10 Mn |
| Dec 31, 2024 | 137.01 Mn |
| Sep 30, 2024 | 137.01 Mn |
| Jun 30, 2024 | 93.25 Mn |
| Mar 31, 2024 | 76.82 Mn |
| Dec 31, 2023 | 85.39 Mn |
| Sep 30, 2023 | 81.84 Mn |
| Jun 30, 2023 | 74.75 Mn |
| Mar 31, 2023 | 39.62 Mn |
| Dec 31, 2022 | 57.70 Mn |
| Sep 30, 2022 | 61.63 Mn |
| Jun 30, 2022 | 22.69 Mn |
| Mar 31, 2022 | 60.11 Mn |
| Dec 31, 2021 | 66.77 Mn |
| Sep 30, 2021 | 216.59 Mn |
API Access
Halozyme Therapeutics Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();